Drug Trial Radar · NCT02772068
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
Last checked: Nov 19, 2026Latest source record: Jun 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Sep 15, 2015
Primary completion
Dec 1, 2018
Study completion Dec 1, 2018
Sponsor
- Lead sponsor
- Benjamin LevineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- May 13, 2016
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Basic science
- Who can join
- All sexes, from 60 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Heart failure with preserved ejection fraction or HFpEF, represents nearly 50% of all heart failure cases and is particularly common in the elderly. The disease has no current treatment options. Symptoms typically occur during exertion or exercise and is likely the result of increased cardiac and pulmonary congestion as a result of impaired diastolic function. Istaroxime is a novel activator of SERCA2a, an important regulator of calcium uptake within the myocyte. We will test the hypothesis that Istaroxime will improve diastolic function during exercise in HFpEF patients which in turn will reduce cardiac and pulmonary congestion.
Conditions
- Heart Failure, Congestive
Interventions
IstaroximeDrug
Subjects will be given Istaroxime, a novel SERCA2a activator one hour prior and during exercise.
ExerciseOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in cardiac filling pressures (pulmonary capillary wedge pressure) during exercise with IstaroximeTime frame: Immediate; 90 minutes after infusion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Institute for Exercise and Environmental Medicine
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.